Inovio Pharmaceuticals, Inc.INONASDAQ

Revenue (LTM)

$65343

-70.0% YoY

Net Income (LTM)

$-85M

+20.8% YoY

Free Cash Flow

$-88.6B

Revenue CAGR (5Y)

-61.2%

Marginsdeclining

FCF($88.6B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	2	10↑478.2%	1↓91.9%	0↓73.8%	0↓70.0%
Gross Profit	2	10↑478.2%	1↓91.9%	0↓73.8%	-3↓1442.6%
Operating Income	-301	-268↑11.2%	-144↑46.2%	-112↑21.9%	-87↑22.8%
Net Income	-304	-280↑7.9%	-135↑51.7%	-107↑20.6%	-85↑20.8%
EBITDA	-297	-271↑8.7%	-130↑51.9%	-104↑20.3%	-84↑19.3%
EPS Diluted	-1.42	-14.07↓890.8%	-6.09↑56.7%	-3.95↑35.1%	-1.81↑54.2%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	71	46↓34.9%	14↓69.1%	66↑359.9%	44↓32.7%
Total Current Assets	448	315↓29.7%	153↓51.4%	98↓36.1%	61,123↑62379.1%
Total Assets	496	349↓29.7%	171↓51.0%	113↓33.8%	74,310↑65546.5%
Total Current Liabilities	66	97↑47.3%	43↓56.1%	35↓17.0%	43,669↑123517.4%
Total Liabilities	96	126↑31.1%	54↓57.5%	45↓16.6%	50,214↑112251.6%
Total Equity	400	222↓44.4%	117↓47.2%	69↓41.6%	24↓64.8%
Total Debt	33	32↓2.9%	30↓5.8%	12↓60.7%	9,368↑78852.2%
Net Debt	-38	-14↑62.6%	16↑211.5%	-54↓439.3%	9,324↑17382.4%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-216	-216↓0.2%	-124↑42.5%	-104↑16.3%	-88,629↓85057.9%
Capital Expenditure	-1	-1↑21.3%	-0↑66.9%	-0↓52.0%	-0↑41.4%
Free Cash Flow	-217	-217↓0.1%	-125↑42.6%	-105↑16.1%	-88,629↓84660.6%
Stock-Based Comp	26	23↓14.4%	11↓50.9%	7↓40.4%	3,756↑56848.1%
Net Change in Cash	-180	-25↑86.2%	-32↓29.0%	52↑260.9%	-21,540↓41923.2%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance